2% Chlorhexidine (CHX) vs CaOH2 (CH) Calcium Hydroxide Paste as an Intracanal Medicament
Use of 2% Chlorhexidine (CHX) as Intracanal Medicament in Endodontic Emergencies and to Compare Its Use and Effectiveness With CaOH2 (CH) Calcium Hydroxide Paste
Sponsor: University of Southern California
This PHASE3 trial investigates Apical Periodontitis and is currently ongoing. University of Southern California leads this study, which shows 8 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Oct 2025 — Present [monthly]
Unknown PHASE3
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Oct 2025 [monthly]
Not Yet Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE3
-
Apr 2023 — Jul 2024 [monthly]
Not Yet Recruiting PHASE3
Status: Unknown Status → Not Yet Recruiting
-
Mar 2022 — Apr 2023 [monthly]
Unknown Status PHASE3
Status: Enrolling By Invitation → Unknown Status
▶ Show 3 earlier versions
-
Jan 2021 — Mar 2022 [monthly]
Enrolling By Invitation PHASE3
-
May 2019 — Jan 2021 [monthly]
Enrolling By Invitation PHASE3
-
Nov 2018 — May 2019 [monthly]
Enrolling By Invitation PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Southern California
For direct contact, visit the study record on ClinicalTrials.gov .